<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01333735</url>
  </required_header>
  <id_info>
    <org_study_id>COG AGE</org_study_id>
    <nct_id>NCT01333735</nct_id>
  </id_info>
  <brief_title>Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon</brief_title>
  <acronym>COG AGE</acronym>
  <official_title>Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the impact of adjuvant chemotherapy on cognitive
      function in patients aged over 65 and suffering from breast cancer or colon.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>impact of memory impairment</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 24 months after chemotherapy</time_frame>
    <description>Assessing the impact of memory impairment induced by chemotherapy and study their evolution over time, with patients over 65 years treated in the adjuvant setting for breast cancer.
Evaluated by auto-questionnary an tests with a neuropsychologist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlations between disorders of cognitive functions and parameters of quality of life</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 24 months after chemotherapy</time_frame>
    <description>Studying the correlations between disorders of cognitive functions and parameters of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between performance and onco-geriatric cognitive</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 24 months after chemotherapy</time_frame>
    <description>Examine the relationship between performance and onco-geriatric cognitive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological disturbances</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 24 months after chemotherapy</time_frame>
    <description>Search for biological disturbances may be related to cognitive impairment observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of age</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 24 months after chemotherapy</time_frame>
    <description>Assess the impact of age on the magnitude of cognitive impairment in patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lived of the entourage</measure>
    <time_frame>Before chemotherapy (baseline), end of chemotherapy and follow-up up to 12 months after chemotherapy</time_frame>
    <description>- Assess the impact and cognitive impairment of patients'experiences of the circle (translational research)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with chemotherapy group</arm_group_label>
    <description>Patients with breast or colon cancer must beginning a chemotherapy (colon group was ended)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without chemotherapy group</arm_group_label>
    <description>patient with breast or colon cancer should not receive chemotherapy (colon group was ended)</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      NFS, uree, creatinin, ASAT, ALAT, PAL, GGT, Vit D, B12, Folates, Albumin, lipid, TSH,
      testosteron, oestradiol, LH, FSH, TP, TCA, D-Dimeres, Homocystéine, plasmatic
      biomarkers(protein S100, NSE, CRP, IL6)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with chemotherapy group and patients without chemotherapy group (control group)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for patients with chemotherapy :

          -  Patient(e) aged over 65 years

          -  Non metastatic breast cancer

          -  Adjuvant chemotherapy Breast cancer: FEC, including Docetaxel Protocols

          -  No major cognitive impairment

          -  Lack of personality disorders and psychiatric disorders evolutionary

          -  Having signed the informed consent of study participation

        Inclusion Criteria for patients without chemotherapy (control group):

          -  Patient(e) aged over 65 years

          -  Breast cancer

          -  Patients receiving no adjuvant chemotherapy

          -  No major cognitive impairment

          -  Lack of personality disorders and psychiatric disorders evolutionary

          -  Having signed the informed consent of study participation

          -  Matching on age, sex, cultural level and tumor location

        Exclusion Criteria for patients with chemotherapy :

          -  Metastatic

          -  Cancer primitive other than breast

          -  Patients under 65 years

          -  Patients with adjuvant chemotherapy is associated with targeted therapy

          -  Patients who have received other cancer treatments (chemotherapy or radiotherapy
             brain)

          -  disorders of higher functions existing in the administration of chemotherapy

          -  Pathology psychiatric evolutionary

          -  Refusal of participation

          -  Patients unable to meet the cognitive tests

          -  Drug use

          -  Heavy drinking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>66 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence JOLY-LOBBEDEZ, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre François Baclesse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Université</name>
      <address>
        <city>Bruxelles</city>
        <zip>1050</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INSERM</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre François BACLESSE</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Pitié-Sapètrière</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital TENON</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75970</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital gériatrique des Bateliers</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Université</name>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <zip>59653</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU, Hôpital Bois Guillaume</name>
      <address>
        <city>Rouen</city>
        <state>Seine Maritime</state>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Rouen</city>
        <state>Seine Maritime</state>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Henri BECQUEREL</name>
      <address>
        <city>Rouen</city>
        <state>Seine Maritime</state>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles FOIX</name>
      <address>
        <city>IVRY sur SEINE</city>
        <zip>94206</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopitaux universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2011</study_first_submitted>
  <study_first_submitted_qc>April 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2011</study_first_posted>
  <last_update_submitted>September 3, 2015</last_update_submitted>
  <last_update_submitted_qc>September 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2015</last_update_posted>
  <responsible_party>
    <name_title>Pr Florence JOLY-LOBBEDEZ</name_title>
    <organization>Centre François Baclesse</organization>
  </responsible_party>
  <keyword>cognitive functions</keyword>
  <keyword>quality of life</keyword>
  <keyword>breast cancer</keyword>
  <keyword>chemotherapy</keyword>
  <keyword>ages patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

